These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 32375710)
1. Management of a pregnant patient with chylomicronemia from a novel mutation in GPIHBP1: a case report. Lin MH; Tian XH; Hao XL; Fei H; Yin JL; Yan DD; Li T BMC Pregnancy Childbirth; 2020 May; 20(1):272. PubMed ID: 32375710 [TBL] [Abstract][Full Text] [Related]
2. A novel mutation in GPIHBP1 causes familial chylomicronemia syndrome. Paquette M; Hegele RA; Paré G; Baass A J Clin Lipidol; 2018; 12(2):506-510. PubMed ID: 29452893 [TBL] [Abstract][Full Text] [Related]
3. Clinical and genetic features of 3 patients with familial chylomicronemia due to mutations in GPIHBP1 gene. Rabacchi C; D'Addato S; Palmisano S; Lucchi T; Bertolini S; Calandra S; Tarugi P J Clin Lipidol; 2016; 10(4):915-921.e4. PubMed ID: 27578123 [TBL] [Abstract][Full Text] [Related]
6. Genotype-phenotype relationships in patients with type I hyperlipoproteinemia. Chokshi N; Blumenschein SD; Ahmad Z; Garg A J Clin Lipidol; 2014; 8(3):287-95. PubMed ID: 24793350 [TBL] [Abstract][Full Text] [Related]
7. Molecular analysis of three known and one novel LPL variants in patients with type I hyperlipoproteinemia. Caddeo A; Mancina RM; Pirazzi C; Russo C; Sasidharan K; Sandstedt J; Maurotti S; Montalcini T; Pujia A; Leren TP; Romeo S; Pingitore P Nutr Metab Cardiovasc Dis; 2018 Feb; 28(2):158-164. PubMed ID: 29288010 [TBL] [Abstract][Full Text] [Related]
8. Clinical and biochemical features of different molecular etiologies of familial chylomicronemia. Hegele RA; Berberich AJ; Ban MR; Wang J; Digenio A; Alexander VJ; D'Erasmo L; Arca M; Jones A; Bruckert E; Stroes ES; Bergeron J; Civeira F; Witztum JL; Gaudet D J Clin Lipidol; 2018; 12(4):920-927.e4. PubMed ID: 29748148 [TBL] [Abstract][Full Text] [Related]
9. Molecular basis of the familial chylomicronemia syndrome in patients from the National Dyslipidemia Registry of the Spanish Atherosclerosis Society. Ariza MJ; Rioja J; Ibarretxe D; Camacho A; Díaz-Díaz JL; Mangas A; Carbayo-Herencia JA; Ruiz-Ocaña P; Lamíquiz-Moneo I; Mosquera D; Sáenz P; Masana L; Muñiz-Grijalvo O; Pérez-Calahorra S; Valdivielso P; J Clin Lipidol; 2018; 12(6):1482-1492.e3. PubMed ID: 30150141 [TBL] [Abstract][Full Text] [Related]
10. Familial chylomicronemia syndrome: case reports of siblings with deletions of the GPIHBP1 gene. Kim KY; Heo YJ; Ko JM; Lee YA; Shin CH; Ki CS; Lee YJ BMC Endocr Disord; 2024 Apr; 24(1):47. PubMed ID: 38622573 [TBL] [Abstract][Full Text] [Related]
11. Identification of a Compound Heterozygous LMF1 Variants in a Patient with Severe Hypertriglyceridemia - Case Report and Literature Review. Cao C; Liu Y; Liu L; Wang X J Atheroscler Thromb; 2024 Jul; 31(7):1106-1111. PubMed ID: 38462482 [TBL] [Abstract][Full Text] [Related]
12. Type 1 hyperlipoproteinemia due to a novel deletion of exons 3 and 4 in the GPIHBP1 gene. Berge KE; Retterstøl K; Romeo S; Pirazzi C; Leren TP Atherosclerosis; 2014 May; 234(1):30-3. PubMed ID: 24589565 [TBL] [Abstract][Full Text] [Related]
13. A novel GPIHBP1 mutation related to familial chylomicronemia syndrome: A series of cases. Lima JG; Helena C Nobrega L; Moura Bandeira FT; Pires Sousa AG; Medeiros de Araujo Macedo TB; Cavalcante Nogueira AC; Fernandes de Oliveira Filho A; Alves RJ; Costa Gurgel Castelo MH; Silva Coelho FM; Maia RE; Lima DN; Timoteo ARS; de Melo Campos JTA Atherosclerosis; 2021 Apr; 322():31-38. PubMed ID: 33706081 [TBL] [Abstract][Full Text] [Related]
14. Familial chylomicronemia syndrome: an under-recognized cause of severe hypertriglyceridaemia. Baass A; Paquette M; Bernard S; Hegele RA J Intern Med; 2020 Apr; 287(4):340-348. PubMed ID: 31840878 [TBL] [Abstract][Full Text] [Related]
15. Incidental finding of severe hypertriglyceridemia in children. Role of multiple rare variants in genes affecting plasma triglyceride. Buonuomo PS; Rabacchi C; Macchiaiolo M; Trenti C; Fasano T; Tarugi P; Bartuli A; Bertolini S; Calandra S J Clin Lipidol; 2017; 11(6):1329-1337.e3. PubMed ID: 28951076 [TBL] [Abstract][Full Text] [Related]
16. Familial chylomicronemia syndrome and response to medium-chain triglyceride therapy in an infant with novel mutations in GPIHBP1. Ahmad Z; Wilson DP J Clin Lipidol; 2014; 8(6):635-639. PubMed ID: 25499947 [TBL] [Abstract][Full Text] [Related]
17. Etiology and emerging treatments for familial chylomicronemia syndrome. Spagnuolo CM; Hegele RA Expert Rev Endocrinol Metab; 2024 Jul; 19(4):299-306. PubMed ID: 38866702 [TBL] [Abstract][Full Text] [Related]
18. Rare Variants in Triglycerides-Related Genes Increase Pancreatitis Risk in Multifactorial Chylomicronemia Syndrome. Paquette M; Amyot J; Fantino M; Baass A; Bernard S J Clin Endocrinol Metab; 2021 Aug; 106(9):e3473-e3482. PubMed ID: 34019660 [TBL] [Abstract][Full Text] [Related]
19. Familial Chylomicronemia Syndrome: A Clinical Guide For Endocrinologists. Falko JM Endocr Pract; 2018 Aug; 24(8):756-763. PubMed ID: 30183397 [TBL] [Abstract][Full Text] [Related]